K
Krebs Biochemicals & Industries
KREBSBIO Share Price
Healthcare57.04
as on 27 Feb 2026 at 15:27
Market Cap
₹123 Cr
PE Ratio
-5.50
ROCE
-32.07%
KREBSBIO Fundamentals
Company Valuation
Market Cap (₹ Cr.)
123
PE Ratio
-5.50
PB Ratio
-0.78
Dividend Yield
-
ROE
18.42%
ROCE
-32.07%
Book Value (₹)
-74.60
Face Value (₹)
10.00
Share Holding Pattern
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|
| Promoters | 72.74% | 72.74% | 72.74% | 72.74% | 72.74% |
| Domestic Institutional Investors (DII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Foreign Institutional Investors (FII) | 0.50% | 0.50% | 0.50% | 0.50% | 0.00% |
| Public Investors | 20.02% | 20.42% | 19.73% | 19.70% | 19.80% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
KREBSBIO Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Microcap
BSE Scrip Code
524518
NSE Scrip Name
KREBSBIO
ISIN
INE268B01013



